Investigation of germline GFRα-1 mutations in Hirschsprung disease

Journal of Medical Genetics

Volumn 36, Issue 3, 1999, Pages 217-220

  Myers, Shirley M ^a   Salomon, Remi ^b   Goessling, Antje ^c,d   Pelet, Anna ^b   Eng, Charis ^d   Von Deimling, Andreas ^c   Lyonnet, Stanislas ^b   Mulligan, Lois M ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

GDNF; GFR 1; Hirschsprung disease; RET

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE MUTATION; GERM LINE; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ONCOGENE RET; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR GENE;

ALTERNATIVE SPLICING; DROSOPHILA PROTEINS; EXONS; GERM-LINE MUTATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HIRSCHSPRUNG DISEASE; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; VARIATION (GENETICS);

EID: 0032985557     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Lin LFH, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1130-2.
2. Kotzbauer FT, Lampe PA, Heuckeroth RO, et al. Neurturin, a relative of glial-cell-line derived neurotrophic factor. Nature 1996;384:467-70.
3. Jing S, Wen D, Yu Y, et al. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 1996;85:1113-24.
4. Sanicola M, Hession C, Worley D, et al. Glial cell line-derived neurotrophic factor dependent RET activation can be mediated by two different cell-surface accessory proteins. Pros Natl Acad Sci USA 1997;94:6238-43.
5. Treanor JJS, Goodman L, de Sauvage F, et al. Characterization of a multicomponent receptor for GDNF. Nature 1996;382:80-3.
6. Baloh RH, Tamsey MG, Golden JP, et al. TrnR2, a novel receptor that mediates neurturin and GDNF signalling through Ret. Neuron 1997;18:793-802.
7. Suvanto P, Wartiovaara K, Lindahl M, et al. Cloning, mRNA distribution and chromosomal localisation of the gene for glial cell line-derived neurotrophic factor receptor β, a homologue of GDNFR-α. Hum Mol Genet 1997;6: 1267-73.
8. GFRα Nomenclature Committee. Nomenclature of GPI-linked receptors for the GDNF ligand family. Neuron 1997;19:405.
9. Klein RD, Sherman D, Ho WH, et al. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 1997;387:717-21.
10. Jing S, Yu Y, Fang M, et al. GFRα-2 and GFRα-3 are two new receptors for ligands of the GDNF family. J Biol Chem 1997;272:33111-17.
11. Avantaggiato V, Dathan NA, Grieco M, et al. Developmental expression of the RET protooncogene. Cell Growth Diff 1994;5:305-11.
12. Pachnis V, Mankoo B, Costantini F. Expression of the c-ret proto-oncogene during mouse embryo genesis. Development 1993;119:1005-17.
13. Trupp M, Belluardo N, Funakoshi H, Ibáñez CF. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS. J Neurosci 1997;17:3554-67.
14. Hellmich HL, Kos L, Cho ES, Mahon KA, Zimmer A. Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech Dev 1996;54:95-105.
15. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994;367:380-3.
16. Sánchez MP, Silos-Santiago I, Frisén J, Lira SA, Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 1996;382:70-3.
17. Pichel JG, Shen L, Sheng HZ, et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996;382:73-6.
18. Moore MW, Klein RD, Fariñas I, et al. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996;382:76-9.
19. Passarge E. The genetics of Hirschsprung's disease. Evidence for heterogeneous etiology and a study of sixty-three families. N Engl J Med 1967;276:138-43.
20. Attié T, Pelet A, Edery P, et al. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 1995;4:1381-6.
21. Chakravarti A. Endothelin receptor-mediated signaling in Hirschsprung disease. Hum Mol Genet 1996;5:303-7.
22. Angrist M, Bolk S, Halushka M, Lapchak PA, Chakravarti A. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat Genet 1996;14:341-3.
23. Salomon R, Attié T, Pelet A, et al. Germline mutations of the RET ligand, GDNF, are not sufficient to cause Hirschsprung disease. Nat Genet 1996;14:345-7.
24. Ivanchuk SM, Myers SM, Eng C, Mulligan LM. De novo mutation of GDNF, ligand of the RET/GDNFR-α receptor complex in Hirschsprung disease. Hum Mol Genet 1996;5:2023-26.
25. Shefelbine SE, Khorana S, Schulz PN, et al. Mutational analysis of the GDNF/RET-GDNFRα signaling complex in a kindred with vesicoureteral reflux. Hum Genet 1998;102:474-8.
26. Eng C, Myers SM, Kogon MD, et al. Genomic structure and chromosomal localisation of the human GDNFR-α gene. Oncogene 1998;16:597-602.
27. Angrist M, Jing S, Bolk S, et al. Human GFRA1: cloning, mapping, genomic structure and evaluation as a candidate gene for Hirschsprung disease susceptibility. Genomics 1998;48:354-62.
28. Ito S, Iwashita T, Asai N, et al. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. Cancer Res 1997;57:2870-2.
29. Carlomagno F, Salvatore G, Cirafici AM, et al. The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. Cancer Res 1997;57:391-5.
30. Amiel J, Attié T, Jan D, et al. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum Mol Genet 1996;5:355-7.
31. Kusafuka T, Wang Y, Puri P. Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease. Hum Mol Genet 1996;5:347-9.
32. Pingault V, Bondurand N, Kuhlbrodt K, et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 1998;18:171-3.